# DeFi Capital Markets, Inc.: overview DCM · NYSE · CIK 102109 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dcm.md) · [Financials](/companies/dcm/financials.md) · [Filings](/companies/dcm/filings.md) · [Insiders](/companies/dcm/insiders.md) Latest reported revenue: [$109.6k](/filings/0001104659-26-097233.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001104659-26-097233). ## Last eight quarters | Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [7,203](/filings/0001104659-25-114128.md) | [5,535](/filings/0001104659-26-017568.md) | [6,227 d](/filings/0001104659-26-080359.md) | [3,824](/filings/0001104659-26-097233.md) | [760](/filings/0001104659-25-114128.md) | [22.5](/filings/0001104659-26-017568.md) | [240 d](/filings/0001104659-26-080359.md) | [110](/filings/0001104659-26-097233.md) | | Gross margin | % | [27.7%](/filings/0001104659-25-114128.md) | [18.5%](/filings/0001104659-26-017568.md) | [43.7% d](/filings/0001104659-26-080359.md) | [18.2%](/filings/0001104659-26-097233.md) | [60.4%](/filings/0001104659-25-114128.md) | [(1228.4%)](/filings/0001104659-26-017568.md) | [(30.3%) d](/filings/0001104659-26-080359.md) | [8.3%](/filings/0001104659-26-097233.md) | | Operating margin | % | [9.4%](/filings/0001104659-25-114128.md) | [(15.7%)](/filings/0001104659-26-017568.md) | [15.9% d](/filings/0001104659-26-080359.md) | [(13.9%)](/filings/0001104659-26-097233.md) | [(122.2%)](/filings/0001104659-25-114128.md) | [(9700.4%)](/filings/0001104659-26-017568.md) | [(418.8%) d](/filings/0001104659-26-080359.md) | [(672.9%)](/filings/0001104659-26-097233.md) | | Net margin | % | [8.0%](/filings/0001104659-26-017568.md) | [(16.9%)](/filings/0001104659-26-017568.md) | [20.9% d](/filings/0001104659-26-080359.md) | [47.3%](/filings/0001104659-26-097233.md) | [(131.6%)](/filings/0001104659-26-017568.md) | [(10143.1%)](/filings/0001104659-26-017568.md) | [(419.8%) d](/filings/0001104659-26-080359.md) | [(604.3%)](/filings/0001104659-26-097233.md) | | Diluted EPS | $ per share | [0.25](/filings/0001104659-25-114128.md) | [(0.40)](/filings/0001104659-26-017568.md) | not reported | [0.78](/filings/0001104659-26-097233.md) | [(0.43)](/filings/0001104659-25-114128.md) | [(0.99)](/filings/0001104659-26-017568.md) | not reported | [(0.23)](/filings/0001104659-26-097233.md) | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [(733)](/filings/0001104659-26-097233.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [19.5](/filings/0001410578-23-001476.md) | [22.2](/filings/0001410578-24-001074.md) | [19.5](/filings/0001410578-25-001522.md) | [23.6](/filings/0001104659-26-080359.md) | [4.8](/filings/0001104659-26-080359.md) | | Gross margin | % | [30.9%](/filings/0001410578-23-001476.md) | [28.6%](/filings/0001410578-24-001074.md) | [28.7%](/filings/0001410578-25-001522.md) | [29.0%](/filings/0001104659-26-080359.md) | [16.6%](/filings/0001104659-26-080359.md) | | Operating margin | % | [0.4%](/filings/0001410578-23-001476.md) | [4.4%](/filings/0001410578-24-001074.md) | [(2.9%)](/filings/0001410578-25-001522.md) | [1.7%](/filings/0001104659-26-080359.md) | [(96.0%)](/filings/0001104659-26-080359.md) | | Net margin | % | [(0.4%)](/filings/0001410578-23-001476.md) | [3.2%](/filings/0001410578-24-001074.md) | [(3.6%)](/filings/0001410578-25-001522.md) | [2.1%](/filings/0001104659-26-080359.md) | [(51.3%)](/filings/0001104659-26-080359.md) | | Diluted EPS | $ per share | [(0.03)](/filings/0001410578-23-001476.md) | [0.31](/filings/0001410578-24-001074.md) | [(0.30)](/filings/0001410578-25-001522.md) | [0.22](/filings/0001104659-26-080359.md) | [(1.04)](/filings/0001104659-26-080359.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/dcm/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [TRUIST FINANCIAL CORP](/funds/92230.md) | 2026-06-30 | $145.2k | 37,516 | | New +37,516 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $122.8k | 26,745 | | Unchanged | | [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $83.8k | 18,256 | | Reduced −6,756 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $77.5k | 16,889 | | Unchanged | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $66.0k | 14,377 | | Unchanged | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $63.5k | 13,829 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $27.6k | 6,017 | | Added +1,909 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $12.1k | 2,635 | | Added +830 | | [JONES FINANCIAL COMPANIES LLLP](/funds/815917.md) | 2026-06-30 | $11.5k | 2,510 | | Unchanged | | [CWM, LLC](/funds/1535847.md) | 2026-03-31 | $11.3k | 2,061 | | Not compared | ## Recent filings [All 464 filings](/companies/dcm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-20 | 16:30 ET | [DEF 14A](/filings/0001104659-26-117433.md) | Proxy statement, period 2026-11-18 | 0001104659-26-117433 | | 2026-10-15 | 16:30 ET | [8-K](/filings/0001104659-26-116259.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-116259 | | 2026-10-09 | 16:30 ET | [8-K](/filings/0001104659-26-115059.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-26-115059 | | 2026-10-07 | 16:30 ET | [8-K](/filings/0001104659-26-114373.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-114373 | | 2026-10-01 | 17:31 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002701.md) | Ownership report, active investor, amended | 0000921895-26-002701 | | 2026-08-31 | 20:00 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002441.md) | Ownership report, active investor, amended | 0000921895-26-002441 | | 2026-08-21 | 20:05 ET | [SCHEDULE 13D/A](/filings/0000921895-26-002270.md) | Ownership report, active investor, amended | 0000921895-26-002270 | | 2026-08-14 | 16:31 ET | [10-Q](/filings/0001104659-26-097233.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097233 | | 2026-08-07 | 16:57 ET | [8-K](/filings/0001104659-26-092769.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-26-092769 | | 2026-07-31 | 21:00 ET | [SCHEDULE 13D/A](/filings/0001193805-26-001013.md) | Ownership report, active investor, amended | 0001193805-26-001013 | ## Latest annual report [Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001104659-26-080359.md), filed Jul 2, 2026. ## Forecast league Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/0fe797b9-98ec-46c2-8fab-c2d97f41191b) ## About the filer - CIK: 102109 - Tickers: DCM, UUU - Exchange: NYSE - SIC code: 5065 Wholesale-Electronic Parts & Equipment, NEC - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:32 ET. No prices; not investment advice.